Benzinga - During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
Kennametal Inc. (NYSE: KMT)
- Dividend Yield: 3%
- Barclays analyst Julian Mitchell maintained an Equal-Weight rating and raised the price target from $25 to $27 on Feb. 8, 2023. This analyst has an accuracy rate of 72%.
- Loop Capital analyst Chris Dankert maintained a Hold rating and increased the price target from $22 to $28 on Feb. 9, 2023. This analyst has an accuracy rate of 64%.
- Recent News: Kennametal, during February, posted better-than-expected Q2 results.
- Dividend Yield: 3.37%
- BMO Capital analyst Fadi Chamoun maintained a Market Perform rating and raised the price target from $175 to $185 on Feb. 1, 2023. This analyst has an accuracy rate of 73%.
- Evercore ISI Group analyst Jonathan Chappell maintained an In-Line rating and boosted the price target from $181 to $203 on Dec. 19, 2022. This analyst has an accuracy rate of 76%.
- Recent News: UPS reported better-than-expected Q4 EPS, raised its dividend and announced a $5 billion repurchase program. The company is expected to release Q1 results on April 25, 2023.
- Dividend Yield: 3.45%
- Truist Securities analyst Tobey Sommer maintained a Hold rating on the stock and raised the price target from $80 to $92 on Feb. 1, 2023. This analyst has an accuracy rate of 76%.
- JP Morgan analyst Andrew Steinerman downgraded the stock from Overweight to Neutral with a price target of $78 on July 11, 2022. This analyst has an accuracy rate of 76%.
- Recent News: ManpowerGroup posted better-than-expected Q4 sales. The company is expected to release Q1 earnings results before the market opens on April 20, 2023.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.